[Collateral dilatation therapy in coronary and peripheral arterial occlusive diseases. Experimental and clinical experiences with 1-benzyl-3-ethyl-6,7-dimethoxyisoquinoline hydrochloride (BEN)].
D000368:Aged; D001158:Arteries / Q000187:drug effects; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D001593:Benzyl Compounds / Q000494:pharmacology / Q000627:therapeutic use; D003097:Collateral Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy; D004617:Embolism / Q000188:drug therapy; D006439:Hemodynamics; D006801:Humans; D007273:Injections, Intramuscular; D007546:Isoquinolines / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D010991:Plethysmography; D011343:Procaine / Q000494:pharmacology / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects; D014652:Vascular Diseases / Q000188:drug therapy*; D014655:Vascular Resistance / Q000187:drug effects
D001593:Benzyl Compounds; D007546:Isoquinolines; D011343:Procaine
Kollateralerweiternde Therapie bei koronaren und peripheren arteriellen Verschlusskrankheiten. Experimentelle und klinische Erfahrungen mit 1-Benzyl-3-aethyl-6,7-dimethoxy-isochinolin-hydrochlorid (BEN)